Login / Signup
RARRES1 inhibits hepatocellular carcinoma progression and increases its sensitivity to lenvatinib through interaction with SPINK2.
Yarong Guo
Bao Chai
Hezhao Zhang
Xinhao Chai
Yan Chen
Jun Xu
Liwei Qin
Yuting Chai
Published in:
Biology direct (2024)
Our findings highlighted that RARRES1 can inhibit HCC progression and regulate HCC sensitivity to lenvatinib by interacting SPINK2, representing a new tumor suppressor RARRES1/SPINK2 axis in HCC that modulates sensitivity to lenvatinib.
Keyphrases
</>